Research News and Research

RSS

Researchers investigate aberrant expression of nuclear matrix proteins in gastric cancer cells

Gastric cancer is the most common malignant gastrointestinal cancer and accounts for 25% of cancer deaths. Nuclear matrix, a filamentous protein framework for eukaryotic cellular chromatin, closely relates to DNA duplication and transcription. Research on nuclear matrix proteins will provide insight into how tumors developed.

7 May 2010

Newly updated informational website on E. coli

An outbreak of E. coli O145 in three states has hospitalized 12, three of whom have developed hemolytic Uremic syndrome, a severe complication of E. coli infection. Victims in Michigan, Ohio, and New York are ill with E. coli O145, which has been linked to a recall of tainted lettuce by Freshway Foods.

7 May 2010

Creator of California Tay-Sachs Disease Prevention Program among the honorees

A mere 40 years ago, parents didn't know they were carriers of the Tay-Sachs disease until after they'd given birth to a child with this fatal genetic disorder.

7 May 2010

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

The National Institutes of Health has awarded a $2.7-million grant to Kent State University for a collaborative research project with Case Western Reserve University School of Nursing, Summa Health System in Akron and University Hospitals Case Medical Center in Cleveland to study cognitive impairment in heart failure patients.

7 May 2010

Spousal caregivers frequently show memory deficits: Study

Husbands or wives who care for spouses with dementia are six times more likely to develop the memory-impairing condition than those whose spouses don't have it, according to results of a 12-year study led by Johns Hopkins, Utah State University, and Duke University.

7 May 2010

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.

7 May 2010

Icagen reports revenues of $1.5M, net loss of $3.2M for first-quarter 2010

Icagen, Inc. reported today its financial results and operational highlights for the first quarter ended March 31, 2010. For the first quarter of 2010, the Company reported revenues of $1.5 million and a net loss of $3.2 million. As of March 31, 2010, the Company's cash and cash equivalents totaled $14.3 million.

7 May 2010

Threshold Pharmaceuticals reports $6.0M net loss for first-quarter 2010

Threshold Pharmaceuticals, Inc., today reported financial results for the first quarter ended March 31, 2010.

7 May 2010

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

NewCardio, Inc., a cardiac diagnostic technology provider, will unveil its patented CardioBip technology for remote wireless 12-lead detection and monitoring of atrial fibrillation, ischemia and other cardiovascular events at the Heart Rhythm Society 31st Annual Scientific Sessions, May 12-15, 2010, in Denver, Colorado.

7 May 2010

Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its results for the first quarter of fiscal 2010.

7 May 2010

Encouraging B. anthracis to unwittingly unmask itself will help eradicate the pathogen

Anthrax-causing bacteria can be engineered to shed their invisibility cloaks, making it easier for the immune system to eradicate it, according to a new study published in Microbiology. The work could lead to new measures to treat anthrax infection in the event of a biological warfare attack.

7 May 2010

Coffee-ring formation can be used to set standards for biosensor devices: UCLA researchers

The field of biosensing has recently found an unlikely partner in the quest for increased sensitivity: coffee rings. The next time you spill your coffee on a table, look at the spot left after the liquid has evaporated, and you'll notice it has a darker ring around its perimeter that contains a much higher concentration of particles than the center.

7 May 2010

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Scientists with the University of Maryland Dental School and collaborators at three other major universities will report results from the first three years of the world's largest study yet of a mysterious yet common pain syndrome involving the jaw at 8:30 a.m.on May 7 at the annual scientific meeting of the American Pain Society (APS). This year it is being held at the Baltimore Convention Center.

7 May 2010

Plant breeding can be used to produce new types of wheat with enhanced health benefits

Wheat products, and in particular, wholegrain products, are important sources of dietary fibre, vitamins, minerals and other components which are beneficial for human health. Analysis of a diverse range of wheat varieties within the HEALTHGRAIN project of the European Union has shown substantial variation (up to four-fold) in the content and composition of these components.

7 May 2010

Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

Arena Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.

7 May 2010

Nile Therapeutics completes dose escalation in CD-NP Phase II study for acute decompensated heart failure

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed the dose escalation stage of an ongoing Phase II study of CD-NP in patients with acute decompensated heart failure. Nile had previously announced that the study, NIL-CDNP-CT005, was expanded to permit additional dose exploration prior to proceeding to larger Phase II studies.

7 May 2010

Halozyme Therapeutics first-quarter net loss decreases to $11.8 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the first quarter ended March 31, 2010.

7 May 2010

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

In the last three years, a new technique for reprogramming adult cells has given scientists an easier and less controversial way to harness the power of embryonic-like stem cells to study human disease from its earliest beginnings in hopes of gleaning new insights into the root causes of disease and developing new therapies.

7 May 2010

Baby swimming helps develop balance and movement in infants, young children

Teaching babies to swim turns out to be more than just fun. Baby swimmers have better balance and are also better at grasping at things than non-swimmers. This difference persists even when children are five years old, when babies who have been taught to swim still outperform their peers, research from the Norwegian University of Science and Technology (NTNU) shows.

7 May 2010

Comprehensive education program in respiratory therapy

Teleflex Medical has announced the introduction of a comprehensive education program in respiratory therapy, designed to provide an in-depth curriculum focused on maximizing humidification and minimizing challenges through the therapeutic levels outlined in the Respiratory Pyramid of Care. The courses are accredited by the American Association for Respiratory Care.

7 May 2010

Research News and Research

Researchers investigate aberrant expression of nuclear matrix proteins in gastric cancer cells

Newly updated informational website on E. coli

Creator of California Tay-Sachs Disease Prevention Program among the honorees

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

Spousal caregivers frequently show memory deficits: Study

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Icagen reports revenues of $1.5M, net loss of $3.2M for first-quarter 2010

Threshold Pharmaceuticals reports $6.0M net loss for first-quarter 2010

NewCardio to unveil patented CardioBip technology at HRS Annual Scientific Sessions

Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

Encouraging B. anthracis to unwittingly unmask itself will help eradicate the pathogen

Coffee-ring formation can be used to set standards for biosensor devices: UCLA researchers

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Plant breeding can be used to produce new types of wheat with enhanced health benefits

Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

Nile Therapeutics completes dose escalation in CD-NP Phase II study for acute decompensated heart failure

Halozyme Therapeutics first-quarter net loss decreases to $11.8 million

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

Baby swimming helps develop balance and movement in infants, young children

Comprehensive education program in respiratory therapy

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News